These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8193868)

  • 1. Tissue sensitizers.
    Heier SK; Heier LM
    Gastrointest Endosc Clin N Am; 1994 Apr; 4(2):327-52. PubMed ID: 8193868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy and neoplastic disease.
    Kessel D
    Oncol Res; 1992; 4(6):219-25. PubMed ID: 1421614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of reactive oxygen species after photodynamic therapy by porphyrin sensitizers.
    Kolarova H; Nevrelova P; Tomankova K; Kolar P; Bajgar R; Mosinger J
    Gen Physiol Biophys; 2008 Jun; 27(2):101-5. PubMed ID: 18645224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor histopathology following new sensitizers: dithiaporphyrin- and sulfoxaporphyrin-mediated photodynamic therapy.
    Symonowicz K; Ziólkowski P; Chmielewski P; Latos-Grazynski L; Rabczynski J; Osiecka BJ; Milach J
    Anticancer Res; 1999; 19(6B):5385-91. PubMed ID: 10697566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities and trends in the development of new sensitizers for photodynamic therapy and fluorescence diagnosis of tumors].
    Röder B
    Z Erkr Atmungsorgane; 1987; 169(3):218-28. PubMed ID: 3328436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of different cell lines to phototoxic effect of disulfonated chloroaluminium phthalocyanine.
    Kolarova H; Lenobel R; Kolar P; Strnad M
    Toxicol In Vitro; 2007 Oct; 21(7):1304-6. PubMed ID: 17923379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic properties of meta-tetra(hydroxyphenyl)chlorin in human tumor cells.
    Melnikova VO; Bezdetnaya LN; Potapenko AY; Guillemin F
    Radiat Res; 1999 Oct; 152(4):428-35. PubMed ID: 10477920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of photodynamic therapy].
    Takemura T; Nakajima S; Sakata I
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):16-21. PubMed ID: 8546463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Photodynamic therapy as a new prospective method for cancer treatment--II. Overview of photosensitizers].
    Zimcík P; Miletín M
    Ceska Slov Farm; 2004 Nov; 53(6):271-9. PubMed ID: 15630992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tritolylporphyrin dimer as a new potent hydrophobic sensitizer for photodynamic therapy of melanoma.
    Drzewiecka A; Urbańska K; Matuszak Z; Pineiro M; Arnaut LG; Habdas J; Ratuszna A; Stochel G
    Acta Biochim Pol; 2001; 48(1):277-82. PubMed ID: 11440180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic inactivation of Escherichia coli by novel meso-substituted porphyrins by 4-(3-N,N,N-trimethylammoniumpropoxy)phenyl and 4-(trifluoromethyl)phenyl groups.
    Caminos DA; Spesia MB; Durantini EN
    Photochem Photobiol Sci; 2006 Jan; 5(1):56-65. PubMed ID: 16395428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy: update 2006. Part 1: Photochemistry and photobiology.
    Calzavara-Pinton PG; Venturini M; Sala R
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):293-302. PubMed ID: 17309449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy.
    Pandey RK; Goswami LN; Chen Y; Gryshuk A; Missert JR; Oseroff A; Dougherty TJ
    Lasers Surg Med; 2006 Jun; 38(5):445-67. PubMed ID: 16788930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticles as vehicles for delivery of photodynamic therapy agents.
    Bechet D; Couleaud P; Frochot C; Viriot ML; Guillemin F; Barberi-Heyob M
    Trends Biotechnol; 2008 Nov; 26(11):612-21. PubMed ID: 18804298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro photodynamic therapy on melanoma cell lines with phthalocyanine.
    Kolarova H; Nevrelova P; Bajgar R; Jirova D; Kejlova K; Strnad M
    Toxicol In Vitro; 2007 Mar; 21(2):249-53. PubMed ID: 17092686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic and sonodynamic treatment by phthalocyanine on cancer cell lines.
    Kolarova H; Tomankova K; Bajgar R; Kolar P; Kubinek R
    Ultrasound Med Biol; 2009 Aug; 35(8):1397-404. PubMed ID: 19515482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells.
    Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L
    Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy: another option in cancer treatment.
    Bruce S
    Clin J Oncol Nurs; 2001; 5(3):95-9. PubMed ID: 11899376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictions of mathematical models of tissue oxygenation and generation of singlet oxygen during photodynamic therapy.
    Yuan J; Mahama-Relue PA; Fournier RL; Hampton JA
    Radiat Res; 1997 Oct; 148(4):386-94. PubMed ID: 9339955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.